U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT07485881) titled '18F-PSMA PET/CT Versus CT Alone in Assessment of Prostatic Cancer Patients' on March 17.
Brief Summary: To compare the diagnostic performance of 18-F PSMA PET/CT and CT alone in initial staging, assessment of therapy response, as well as evaluation of biochemical recurrence of prostatic cancer patients
The main question it aims to answer is:
Does 18-F PSMA PET/CT have a superior role over CT in evaluation of prostatic cancer patients?
Study Start Date: May 01
Study Type: OBSERVATIONAL
Condition:
Prostate Cancer
Prostate Cancer Metastatic
Prostate Cancer Recurrent
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Assiut Univer...